Assistant Professor, Medicine, Brigham and Women's Hospital, Harvard Medical School
Internal Medicine
Dr. William H. Shrank, MD
|
|
Give Review
William Shrank practices Internal Medicine. He studied medicine at Weill Cornell Medical College of Cornell University. Weill Cornell Medical College of Cornell University is ranked 18/49 in Research/PrimaryCare. William H. Shrank, MD has written publications. He has 101 publications published with PubMed. The lastest publication is: 'Persistent opioid use following Cesarean delivery: patterns and predictors among opioid nave women.'
Publications
- Patients' Satisfaction with and Preference for Telehealth Visits.
- DECISION-MAKING ALIGNED WITH RAPID-CYCLE EVALUATION IN HEALTH CARE.
- Association Between Narrow Pharmacy Networks and Medication Adherence.
- Comparative effectiveness of generic versus brand-name antiepileptic medications.
- New Therapies in the Treatment of High Cholesterol: An Argument to Return to Goal-Based Lipid Guidelines.
- A randomized telephone intervention trial to reduce primary medication nonadherence.
- Variation in Inpatient Consultation Among Older Adults in the United States.
- Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.
- The role of retail pharmacies in CVD prevention after the release of the ATP IV guidelines.
- Costs of new treatments for hepatitis C infection--reply.
- Pharmacy-based Interventions to Reduce Primary Medication Nonadherence to Cardiovascular Medications.
- Cigarette Purchases at Pharmacies by Patients at High Risk of Smoking-Related Illness.
- Quality of care at retail clinics for 3 common conditions.
- A cross-national comparison of 17 countries' insulin glargine drug labels.
- Did HEDIS Get it Right? Evaluating the Quality of a Quality Measure: Adherence to β-Blockers and Cardiovascular Outcomes After Myocardial Infarction.
- New Expensive Treatments for Hepatitis C Infection.
- The CMS Innovation Center: Delivering on the Promise of Payment and Delivery Reform.
- Time series analyses of the effect of FDA communications on use of prescription weight loss medications.
- Impact of electronic prescribing on medication use in ambulatory care.
- Patterns and trends in insulin intensification among patients with type 2 diabetes: A systematic review.
- Trends in Insulin Initiation and Treatment Intensification Among Patients with Type 2 Diabetes.
- Full Prescription Coverage Versus Usual Prescription Coverage After Coronary Artery Bypass Graft Surgery: Analysis From the Post-Myocardial Infarction Free Rx Event an...
- Patterns and predictors of generic narrow therapeutic index drug use among older adults.
- Implementing randomized effectiveness trials in large insurance systems.
- Response letter to eltonsy and colleagues.
- Group-based Trajectory Models: A New Approach to Classifying and Predicting Long-Term Medication Adherence.
- Gender and racial disparities in adherence to statin therapy: A meta-analysis.
- The impact of medication adherence on coronary artery disease costs and outcomes: a systematic review.
- Variations in pill appearance of antiepileptic drugs and the risk of nonadherence.
- Usability of FDA-approved medication guides.
- Barriers to Insulin Progression Among Patients With Type 2 Diabetes: A Systematic Review.
- Association Between the Part D Coverage Gap and Adverse Health Outcomes.
- Therapy. Affect and affirmations--a 'basic' approach to promote adherence.
- An integrated pharmacy-based program improved medication prescription and adherence rates in diabetes patients.
- Trouble getting started: predictors of primary medication nonadherence.
- Helping Our Patients to Adhere to Chronic Medications: A New Arrow for the Quiver.
- Cost-related medication underuse: Prevalence among hospitalized managed care patients.
- Generic drugs: the authors reply.
- Variations in structure and content of online social networks for patients with diabetes.
- Medication adherence: A call for action.
- A Systematic Review of Adherence to Cardiovascular Medications in Resource-Limited Settings.
- Changes in Drug Utilization during a Gap in Insurance Coverage: An Examination of the Medicare Part D Coverage Gap.
- Medicare Part D's Effect on the Under- and Overuse of Medications: A Systematic Review.
- The use of generic drugs in prevention of chronic disease is far more cost-effective than thought, and may save money.
- Conflict of interest in oncology publications: A survey of disclosure policies and statements.
- The Association between Statin use and Outcomes Potentially Attributable to an Unhealthy Lifestyle in Older Adults.
- Are caregivers adherent to their own medications?
- Adherence to statin therapy in elderly patients after hospitalization for coronary revascularization.
- The implications of therapeutic complexity on adherence to cardiovascular medications.
- Healthy user and related biases in observational studies of preventive interventions: a primer for physicians.
- Our bulging medicine cabinets--the other side of medication nonadherence.
- The consequences of requesting "dispense as written".
- Online social networking by patients with diabetes: a qualitative evaluation of communication with Facebook.
- Helping patients simplify and safely use complex prescription regimens.
- Time to fill the doughnuts--health care reform and Medicare Part D.
- Physician perceptions about generic drugs.
- Effect of standardized, patient-centered label instructions to improve comprehension of prescription drug use.
- Statin utilization in nursing home patients after cardiac hospitalization.
- Healthcare information technology interventions to improve cardiovascular and diabetes medication adherence.
- The epidemiology of prescriptions abandoned at the pharmacy.
- Four-dollar generics--increased accessibility, impaired quality assurance.
- At Pitney Bowes, value-based insurance design cut copayments and increased drug adherence.
- Rationale and design of a randomized trial to evaluate an evidence-based prescription drug label on actual medication use.
- Physician effectiveness in interventions to improve cardiovascular medication adherence: a systematic review.
- Changes in drug use and out-of-pocket costs associated with Medicare Part D implementation: a systematic review.
- State generic substitution laws can lower drug outlays under medicaid.
- Medicare beneficiaries' knowledge of and choices regarding Part D, 2005 to the present.
- Primary medication non-adherence: analysis of 195,930 electronic prescriptions.
- Patient, physician, and payment predictors of statin adherence.
- Validating studies of adherence through the use of control outcomes and exposures.
- Medicare Part D--lessons learned and guidance for health-care reform.
- Modes of delivery for interventions to improve cardiovascular medication adherence.
- An evaluation of the relationship between the implementation of a newly designed prescription drug label at Target pharmacies and health outcomes.
- Completeness of retail pharmacy claims data: implications for pharmacoepidemiologic studies and pharmacy practice in elderly patients.
- Measuring concurrent adherence to multiple related medications.
- Can improved prescription medication labeling influence adherence to chronic medications? An evaluation of the Target pharmacy label.
- Patient assistance programs: information is not our enemy.
- Drug company-sponsored patient assistance programs: a viable safety net?
- Communicating drug benefits and risks effectively: there must be a better way.
- Statin adherence and risk of accidents: a cautionary tale.
- Rationale and design of the Study Assessing the Effect of Cardiovascular Medications Provided as Low-cost, Evidence-based Generic Samples (SAMPLES) trial.
- Variation in drug prices at pharmacies: are prices higher in poorer areas?
- Patients' perceptions of generic medications.
- Variability in pharmacy interpretations of physician prescriptions.
- Is there a relationship between patient beliefs or communication about generic drugs and medication utilization?
- The effect of Medicare Part D coverage on drug use and cost sharing among seniors without prior drug benefits.
- A blueprint for pharmacy benefit managers to increase value.
- Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.
- The effect of transitioning to medicare part d drug coverage in seniors dually eligible for medicare and medicaid.
- Free drug samples in the United States: characteristics of pediatric recipients and safety concerns.
- Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies.
- Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries.
- Quality indicators for medication use in vulnerable elders.
- The variability and quality of medication container labels.
- Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use.
- Increasing generic drug use in Medicare Part D: the role of government.
- Educating patients about their medications: the potential and limitations of written drug information.
- Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis.
- Persistent opioid use following Cesarean delivery: patterns and predictors among opioid naïve women.
- Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.
Schools
Weill Cornell Medical College
Georgetown University Hospital
Doctors Specialties
- Internal Medicine
Accepted Insurances
Education
-
Georgetown University Hospital -
Weill Cornell Medical College of Cornell University
Helpful Reviews
Similar Doctors
|
|
Dr. David E. Clapham, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert J. Friedlander Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Margaret A. Stefater, MD |
|
|
Dr. Katherine H. Walker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Audrey M. Provenzano, MD |
|
|
Dr. Neal I. Muni, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen E. Goldfinger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Holly C. Gooding, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sheila E. Chapman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nyra Khetarpal, MD
This Doctor is OpenDoctor Recommended.
|